metformin has been researched along with Neurilemmoma in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Neurilemmoma: A neoplasm that arises from SCHWANN CELLS of the cranial, peripheral, and autonomic nerves. Clinically, these tumors may present as a cranial neuropathy, abdominal or soft tissue mass, intracranial lesion, or with spinal cord compression. Histologically, these tumors are encapsulated, highly vascular, and composed of a homogenous pattern of biphasic fusiform-shaped cells that may have a palisaded appearance. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp964-5)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aspirin has also been associated with decreased VS growth in animal studies." | 1.91 | Metformin Reduces Tumor Growth in a Murine Flank Schwannoma Model. ( Burns, A; Hartman, Y; Hunter, JB; Killeen, DE; Lora Gonzalez, MA; Manickavel, S; Walsh, E; Warram, J, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manickavel, S | 1 |
| Hartman, Y | 1 |
| Burns, A | 1 |
| Lora Gonzalez, MA | 1 |
| Warram, J | 1 |
| Walsh, E | 1 |
| Hunter, JB | 1 |
| Killeen, DE | 1 |
1 other study available for metformin and Neurilemmoma
| Article | Year |
|---|---|
Metformin Reduces Tumor Growth in a Murine Flank Schwannoma Model.
Topics: Animals; Aspirin; Metformin; Mice; Mice, Nude; Neurilemmoma; Neuroma, Acoustic; Rats | 2023 |